Discover trends, market shifts, and competitive outlooks for the gastric ulcers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Gastric Ulcers Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, considerable growth has been observed in the gastric ulcers market. The market size which presently stands at $4.29 billion in 2024, is predicted to escalate to $4.54 billion in 2025, recording a compound annual growth rate (CAGR) of 5.9%. This substantial growth in the historical period is the result of a number of factors. The increasing incidence of helicobacter pylori infections, the frequent usage of nonsteroidal anti-inflammatory drugs (NSAIDs), the increasing number of elderly people worldwide, the rise in gastric ulcer prevention campaigns, and the growing occurrence of stress-related disorders have all contributed to this growth.

In the coming years, the market for gastric ulcers is predicted to experience robust growth, with its size expected to reach $5.64 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.5%. The expected growth during the projected period can be linked to enhancements in diagnostic methodologies, an increase in unhealthy eating patterns, progress in treatment alternatives such as proton pump inhibitors (PPIs), an aging population which increases the disease load, and the growth of healthcare facilities in developing markets. The future major trends include a shift towards combined therapies for better effectiveness, an increasing inclination towards minimally invasive treatment methods, the incorporation of digital health solutions in managing the disease, a surge in demand for over-the-counter (OTC) ulcer drugs, and the growth of personalized medicine strategies in ulcer therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17160&type=smp

Which Factors and External Forces Are Driving Demand in the Gastric Ulcers Market?

The gastric ulcers market is projected to grow due to the expansion of the geriatric population. People typically over the age of 65 constitute this demographic, which comes with unique healthcare points because of age. This group is growing due to the improvement in healthcare, which increases life expectancy and reduces birth rates worldwide. Gastric ulcers are frequently observed in this age group due to the prevalent use of NSAIDs and a reduction in mucosal protection, which often raises the likelihood of complications. For example, the Population Reference Bureau (PRB), a US-based private non-profit organization, forecasted in January 2024 that the population of Americans aged 65 and older would increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, this demographic’s composition of the total population is predicted to grow from 17% to 23%. This shift signifies a substantial increase in the aging trend of the U.S. population. The forecast stresses the need to cater for older adults in different areas. Hence, the growing geriatric population is fuelling the expansion of the gastric ulcers market.

Which Primary Segments of the Gastric Ulcers Market Are Driving Growth and Industry Transformations?

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17160&type=smp

What Are the Fastest-Growing Geographies in the Gastric Ulcers Market?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Gastric Ulcers Market?

Leading businesses in the gastric ulcer market are concentrating on creating ground-breaking goods, such as novel drug formulations, to increase treatment effectiveness and minimize side effects. New formulation drugs are those that have been crafted with unique combinations of component parts, delivery methods, or dosages to enhance their potency, safety, and patient adherence. For example, in June 2024, Indian pharmaceutical production firm Akums Drugs and Pharmaceuticals Ltd., debuted Rabeprazole + Levosulpiride SR Capsules to offer improved relief for disorders such as gastro-oesophageal reflux disease (GERD) and other gastric tract ailments. These products merge a proton pump inhibitor and a prokinetic agent, successfully managing gastrointestinal issues like GERD and gastric ulcers. This mix not only diminishes gastric acid production but also improves gastric mobility, giving complete relief from symptoms like heartburn and digestion issues.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

What Parameters Are Used to Define the Gastric Ulcers Market?

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach’s inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17160

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.